Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Search clinical trials for: RDEA119
Total 2 results
Bayer
Completed
Phase 1 Dose-escalation PK/PD Trial in Advanced Cancer Patients
Advanced Cancer
United States
Bayer
Completed
RDEA119 and Sorafenib Combination Dose Escalation Study
Advanced Cancer
United States, Canada
Sponsors and Collaborators
Societa Italiana di Endoscopia Digestiva
Fondren Orthopedic Group L.L.P.
Donders Institute for Brain, Cognition and Behavior
Norsk Proteinintolerance, Norway
Caritas Freetown
Cardresearch
Alberta Children's Hospital, Calgary, Canada
San MediTech(Huzhou)Co.,Ltd.
The Fifth Affiliated Hospital of Zunyi Medical College
ProteoSys AG
Victor Montori
Diego Hernan Giunta, MD
AMTC & Associates
Elim Pediatric Pharmaceuticals Inc.
CRMBM-CEMEREM
Rui-hua Xu, MD, PhD
Celtaxsys Aus Pty Limited
Ilustre Colegio Profesional de Fisioterapeutas de la Comunidad de Madrid
University Medical Center Goettingen
University Centre for Chronic Diseases Dekkerswald, Groesbeek, NL
View Full List
Medical Conditions
Postcomatose Unawareness State
Gynecologic Cancer
Malignant Ascites Due to Epithelial Carcinoma
Atrial Fibrillation, Postoperative
Stereotactic Radioablation for Ventricular Tachycardia
Analgesics, Antipyretics, and Antirheumatics Causing Adverse Effects in Therapeutic Use
Fever, Sweats, and Hot Flashes
Orbital Tumor
Lymphedema of Arm
Non-dystrophic Myotonias
Tube Disorders Eustachian
Auditory Hallucination, Verbal
Plasmodium Falciparum Malaria (Drug Resistant)
Tularaemia
Spermatogenesis Arrest
Prostate Cancer Recurrent
Non-compressible Torso Hemorrhage
Fibromyalgia Syndrome, Primary
Normal Diameter of Optic Nerve
Disturbance of Activity and Attention
View Full List
Drug Interventions
HB-202 / HB-201 alternating intravenous administration + standard of care regimen including pembrolizumab.
Enzalutamide, Abiraterone
Atezolizumab
Oxycodone, fentanyl
Cetrorelix 78 mg + 78 mg
Epimedium Prenylflavonoids Extract
Lamivudine
Cytarabine ARA-C
PF-00868554
Indoximod
CTx-1301-Dexmethylphenidate 18.75mg (randomized fixed dose)
Flibanserin 100 mg dose every evening
Bortezomib/dexamethasone
SERETIDE Diskus
Mupirocin Calcium
Polyethylene glycol 3350
Methotrexate
Insulin
Topotecan
Ruxolitinib
View Full List
CROs by country
Contract Research Organizations in Belarus
Contract Research Organizations in Benin
Contract Research Organizations in Chile
Contract Research Organizations in Cote d'Ivoire
Contract Research Organizations in Croatia
Contract Research Organizations in Georgia
Contract Research Organizations in Greece
Contract Research Organizations in Guatemala
Contract Research Organizations in Norway
Contract Research Organizations in Panama
Contract Research Organizations in Turkmenistan
Contract Research Organizations in Uganda
Contract Research Organizations in United Kingdom
CRO list by country
CROs in Brazil
SGS
Emergo Group
Parexel
Dokumeds
PPD
Medpace
Synova Health
PRA Health Sciences
Raras CRO
Brazilian Clinical Research Institute (BCRI)
All CROs in Brazil
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe